Relics Pharmaceutical Private Limited
About Relics Pharmaceutical Private Limited
Data last updated:
Relics Pharmaceutical Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2019PTC344482. Its GSTIN is 09AAJCR3636H1Z4 (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Shailendra Singh (Managing Director) and Indravati Singh.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at H No – 327 G/F Kh No – 8/23 Gali No – 5 Shahid Bhagat Singh Colony, Delhi, India – 110092.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.38 Cr, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹1.15 Lakh (net margin 0.8%) and EBITDA of ₹3.76 Lakh (EBITDA margin 2.7%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years.
The company has about 14 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹52 Lakh on record. Court records list 1 case involving the company, including 1 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Relics Pharmaceutical Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH No – 327 G/F Kh No – 8/23 Gali No – 5 Shahid Bhagat Singh Colony, Delhi, India – 110092
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Relics Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Relics Pharmaceutical is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Relics Pharmaceutical Private Limited, buy the company report.
Financials of Relics Pharmaceutical Private Limited
FY 2024 filings availableRelics Pharmaceutical Private Limited reported revenue of ₹1.38 Cr (up 20% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 12% over three years, including 20% growth in the latest year. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.76 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.15 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.7% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Relics Pharmaceutical Private Limited, buy the company report.
Board of directors of Relics Pharmaceutical Private Limited
Relics Pharmaceutical has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Indravati Singh | Director | 16 Jan 2019 | 7 Years 9 Months | Current |
| Shailendra Singh | Managing Director | 11 Aug 2020 | 6 Years 2 Months | Current |
Peer comparison
Relics Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Saurashtra Stone Clinic and Research Institute Pvt Ltd | ₹1.39 Cr (FY 2025) | -10.0% | Rajkot, Gujarat, India | |||
| Magadh Health Point Private Limited | ₹1.39 Cr (FY 2025) | 46.0% | Patna, Bihar, India | |||
| Sushruta Ayurvedic Therapy Center Private Limited | ₹1.39 Cr (FY 2024) | 5.0% | Delhi, India | |||
| Swaraag Health Care Services Private Limited | ₹1.38 Cr (FY 2021) | 0.0% | Hyderabad, Telangana, India | |||
| Maitri Superspeciality Hospital Private Limited | ₹1.38 Cr (FY 2024) | 42.0% | Varanasi, Uttar Pradesh, India | |||
| Relics Pharmaceutical Private Limitedthis company | ₹1.38 Cr (FY 2024) | ₹1.15 Lakh | 0.8% | 20.0% | 14 | Delhi, India |
| Himalaya Scans Private Limited | ₹1.38 Cr (FY 2024) | 39.0% | Vellore, Tamil Nadu, India | |||
| Rchandra Infrastructures Private Limited | ₹1.38 Cr (FY 2025) | -6.0% | Bhagalpur, Bihar, India | |||
| Clancare Lifesciences Private Limited | ₹1.38 Cr (FY 2024) | -25.0% | Manimajra, Chandigarh, India | |||
| Illtill Chemist (OPC) Private Limited | ₹1.38 Cr (FY 2025) | 131.0% | Mumbai, Maharashtra, India | |||
| Medrelief Healthcare Private Limited | ₹1.38 Cr (FY 2025) | 43.0% | Madhubani, Bihar, India |
To see the full peer comparison of Relics Pharmaceutical Private Limited, buy the company report.
Auditor
Relics Pharmaceutical Private Limited is audited by AMIT S R GUPTA & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AMIT S R GUPTA & CO. | FY 2023 | 023925C |
Shareholding
The shareholding of Relics Pharmaceutical Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Relics Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Apr 2024 | 100921115 | Others | ₹10 Lakh | Open | |
| 28 Mar 2024 | 100905890 | Others | ₹32 Lakh | Open | |
| 05 Feb 2024 | 100873648 | Others | ₹10 Lakh | Open |
Total charge records: 3 View all charges
Legal cases
Relics Pharmaceutical Private Limited has 1 court case on record: 1 filed by Relics Pharmaceutical. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Lucknow, Uttar Pradesh | Civil suit | Filed by the company against an individual | Disposed |
To see the full case history of Relics Pharmaceutical Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Relics Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Relics Pharmaceutical Private Limited has a workforce of 14 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.
GST
Relics Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAJCR3636H1Z4 | Uttar Pradesh | Active | 11 Jul 2019 |
To see the full GST registrations and return filing status of Relics Pharmaceutical Private Limited, buy the company report.
Recent activity
Relics Pharmaceutical Private Limited has 5 board changes on record since 2019: 2 appointments and 3 cessations. The latest: Vishnu Kumar Singh ceased to be Director on 20 Jul 2021.
Frequently asked questions
Relics Pharmaceutical is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 January 2019 (7+ years old) and is registered under CIN U51909DL2019PTC344482.
Relics Pharmaceutical has 2 current directors:
- Shailendra Singh - Managing Director
- Indravati Singh - Director
The latest financial statements of Relics Pharmaceutical on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Relics Pharmaceutical is 09AAJCR3636H1Z4, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Relics Pharmaceutical is U51909DL2019PTC344482. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Relics Pharmaceutical has 1 court case on record: 1 filed by the company.
Relics Pharmaceutical was incorporated on 16 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Relics Pharmaceutical by revenue are Saurashtra Stone Clinic and Research Institute Pvt Ltd, Magadh Health Point Private Limited, Sushruta Ayurvedic Therapy Center Private Limited, Swaraag Health Care Services Private Limited, Maitri Superspeciality Hospital Private Limited and 5 more, all in the same principal business activity (other hospital and medical care activities).
Vishnu Kumar Singh ceased to be Director on 20 Jul 2021. Aruna Devi ceased to be Director on 12 Aug 2020. Shailendra Singh was appointed as Managing Director on 11 Aug 2020. Relics Pharmaceutical has 5 board changes on record in total.
The registered office of Relics Pharmaceutical is at H No – 327 GF Kh No – 823 Gali No – 5 Shahid Bhagat Singh Colony, Delhi, India – 110092.
Relics Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.